Vitamin/Mineral Absorption From Two Different Supplements
NCT ID: NCT05336994
Last Updated: 2022-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2022-04-29
2022-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a Marker of Adherence for Tracking Consumption of Nutrient Supplements
NCT04040543
Effects of Collagen Protein on the Amino Acid Profile of the Blood
NCT03749239
Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
NCT02397200
Cyclic Variation in Micronutrient Concentrations and Plasma Volume
NCT03422809
Comparison of Medical Nutritional Supplements
NCT01483976
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants are required to come for two study visits which are 5 to 7 days apart. Health screening will also be done at Study Visit 1. The order of supplement assignment will be randomized, performed in a double-blind manner.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multivitamin/mineral supplement A to B
Participants will be randomly assigned to receive Supplement A and after 5-7 days of follow-up, they will receive Supplement B.
Multivitamin/mineral supplement A
Oral administration of Supplement A
Multivitamin/mineral supplement B
Oral administration of Supplement B
Multivitamin/mineral supplement B to A
Participants will be randomly assigned to receive Supplement B and after 5-7 days of follow-up, they will receive Supplement A.
Multivitamin/mineral supplement A
Oral administration of Supplement A
Multivitamin/mineral supplement B
Oral administration of Supplement B
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multivitamin/mineral supplement A
Oral administration of Supplement A
Multivitamin/mineral supplement B
Oral administration of Supplement B
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18.5-32 kg/m2
* Free from disease
* Normal blood levels in the comprehensive metabolic panel, or values slightly out of range as approved by the study physician
* Normal blood pressure (individuals whose average blood pressure is greater than 140/90 will be excluded from the study)
* Suitable vein structure and access for successful placement of an indwelling catheter, as determined by our nurse phlebotomist
Exclusion Criteria
* Smoking
* Vaping or using cannabis in any form
* Using multivitamin/mineral supplements in the past two months
* Currently taking supplements including botanical supplements, probiotics or fiber
* Fruit consumption ≥ 2 cups/day
* Vegetable consumption ≥ 3 cups/day
* Coffee/tea ≥ 3 cups/day
* Chronic/routine high-intensity exercise
* Any chronic health conditions
* Self-reported malabsorption
* Currently taking prescription drugs
* Indications of substance or alcohol abuse within the last 3 years
* Unable to consent
18 Years
32 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert M. Hackman, PhD
Role: PRINCIPAL_INVESTIGATOR
Research Nutritionist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ragle Human Nutrition Research Center
Davis, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1692409
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.